ABCB11 and Cholestatic liver disease: Tauroursodeoxycholate (TUDC), which is a frequently used drug for cholestatic liver disease in humans, was shown to stimulate the mobilization of ABCB11 from sub-canalicular compartments to the canalicular plasma membrane [60].